BWT-32017-47709
4 vaccinations
11 coded responses
25 check-ins
10 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 940 / CA
- Registered
- 2022-01-18
- Relationship
- Child or adolescent in my care
- Guardian
- 2L4-31858-15771
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-17
Dose 1 — Pfizer-BioNTech
-
2021-06-07
Dose 2 — Pfizer-BioNTech
-
2022-01-18
Registered in v-safe
-
2022-01-18
Dose 3 — Pfizer-BioNTech
-
2022-01-18
Survey response — day 0, dose 3, dependentMedDRA: Somnolence — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolFree text: sleepyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-19
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Migraine — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend schoolFree text: migraineMedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-21
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-22
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-23
-
2022-01-24
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2022-01-25
-
2022-02-01
Survey response — day 14, dose 3, dependentMedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Worsening of ADHD symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Survey response — day 21, dose 3, dependentMedDRA: Fatigue, Somnolence — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased fatigue and sleepiness.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-15
Survey response — day 28, dose 3, dependentMedDRA: Fatigue, Irritability — Feeling: FairFree text: Fatigue, irritabilityMedDRA releases: 2024-11 · check-in free text available
-
2022-02-22
Survey response — day 35, dose 3, dependentMedDRA: Fatigue, Somnolence — Feeling: FairFree text: Fatigue, sleepinessMedDRA releases: 2024-11 · check-in free text available
- 2022-03-01
- 2022-04-19
-
2022-07-19
Survey response — 6 months, dose 3, dependentMedDRA: Sleep disorder, Somnolence — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Daytime sleepiness, nighttime sleep disturbanceMedDRA releases: 2024-11 · check-in free text available
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-09-17
-
2022-09-20
Survey response — days 1–6 daily, dose 4, dependentMedDRA: Somnolence — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: SleepyMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-23
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2022-09-26
-
2022-10-03
Survey response — day 14, dose 4, dependentMedDRA: Cough, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Bad upper respiratory tract infection: cough, congestion, fever. Tests negative for COVID.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Survey response — day 21, dose 4, dependentMedDRA: Cough — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Worsening coughMedDRA releases: 2024-11 · check-in free text available
- 2022-10-17
- 2022-10-24
-
2023-03-18
Survey response — 6 months, dose 4, dependentMedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-17 | Pfizer-BioNTech | No |
| 2 | 2021-06-07 | Pfizer-BioNTech | No |
| 3 | 2022-01-18 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Free text
Release 10 — day 0, dose 3, dependent
Systemic reaction (other): sleepy
Release 10 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): migraine
Release 11 — day 14, dose 3, dependent
Symptoms: Worsening of ADHD symptoms
Release 11 — day 21, dose 3, dependent
Symptoms: Increased fatigue and sleepiness.
Release 11 — day 28, dose 3, dependent
Symptoms: Fatigue, irritability
Release 11 — day 35, dose 3, dependent
Symptoms: Fatigue, sleepiness
Release 12 — 6 months, dose 3, dependent
Symptoms: Daytime sleepiness, nighttime sleep disturbance
Release 12 — days 1–6 daily, dose 4, dependent
Systemic reaction (other): Sleepy
Release 12 — day 14, dose 4, dependent
Symptoms: Bad upper respiratory tract infection: cough, congestion, fever. Tests negative for COVID.
Release 12 — day 21, dose 4, dependent
Symptoms: Worsening cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sleep disorder | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Migraine | · | · | ✓ |
| SRO | Somnolence | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release